Literature DB >> 36254003

Identification of potential hub genes of gastric cancer.

Xu-Dong Zhou1, Ya-Wei Qu2, Li Wang3, Fu-Hua Jia3, Peng Chen4, Yin-Pu Wang5, Hai-Feng Liu1.   

Abstract

BACKGROUND: Gastric cancer (GC) is a malignant tumor originated from gastric mucosa epithelium. It is the third leading cause of cancer mortality in China. The early symptoms are not obvious. When it is discovered, it has developed to the advanced stage, and the prognosis is poor. In order to screen for potential genes for GC development, this study obtained GSE118916 and GSE109476 from the gene expression omnibus (GEO) database for bioinformatics analysis.
METHODS: First, GEO2R was used to identify differentially expressed genes (DEG) and the functional annotation of DEGs was performed by gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The Search Tool for the Retrieval of Interacting Genes (STRING) tool was used to construct protein-protein interaction (PPI) network and the most important modules and hub genes were mined. Real time quantitative polymerase chain reaction assay was performed to verify the expression level of hub genes.
RESULTS: A total of 139 DEGs were identified. The functional changes of DEGs are mainly concentrated in the cytoskeleton, extracellular matrix and collagen synthesis. Eleven genes were identified as core genes. Bioinformatics analysis shows that the core genes are mainly enriched in many processes related to cell adhesion and collagen.
CONCLUSION: In summary, the DEGs and hub genes found in this study may be potential diagnostic and therapeutic targets.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36254003      PMCID: PMC9575828          DOI: 10.1097/MD.0000000000030741

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  52 in total

1.  COL1A2 is a Novel Biomarker to Improve Clinical Prediction in Human Gastric Cancer: Integrating Bioinformatics and Meta-Analysis.

Authors:  Li Rong; Wei Huang; Shangkun Tian; Xiangbo Chi; Pan Zhao; Fengfeng Liu
Journal:  Pathol Oncol Res       Date:  2017-04-11       Impact factor: 3.201

2.  Comparative genomic analysis of collagen gene diversity.

Authors:  Farhan Haq; Nabeel Ahmed; Muhammad Qasim
Journal:  3 Biotech       Date:  2019-02-14       Impact factor: 2.406

3.  Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.

Authors:  Jianjiong Gao; Bülent Arman Aksoy; Ugur Dogrusoz; Gideon Dresdner; Benjamin Gross; S Onur Sumer; Yichao Sun; Anders Jacobsen; Rileen Sinha; Erik Larsson; Ethan Cerami; Chris Sander; Nikolaus Schultz
Journal:  Sci Signal       Date:  2013-04-02       Impact factor: 8.192

4.  Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.

Authors:  Kechao Nie; Laner Shi; Yi Wen; Jinglin Pan; Peiwu Li; Zhihua Zheng; Fengbin Liu
Journal:  Minerva Med       Date:  2019-10-14       Impact factor: 4.806

Review 5.  Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis.

Authors:  Ganji Purnachandra Nagaraju; Ranadheer Dontula; Bassel F El-Rayes; Sajani S Lakka
Journal:  Carcinogenesis       Date:  2014-03-27       Impact factor: 4.944

Review 6.  SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target.

Authors:  Jianguo Feng; Liling Tang
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

8.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.

Authors:  David Cunningham; William H Allum; Sally P Stenning; Jeremy N Thompson; Cornelis J H Van de Velde; Marianne Nicolson; J Howard Scarffe; Fiona J Lofts; Stephen J Falk; Timothy J Iveson; David B Smith; Ruth E Langley; Monica Verma; Simon Weeden; Yu Jo Chua
Journal:  N Engl J Med       Date:  2006-07-06       Impact factor: 91.245

9.  SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.

Authors:  Yijun Qi; Yue Zhang; Zhiqiang Peng; Lei Wang; Kaizhen Wang; Duiping Feng; Junqi He; Junfang Zheng
Journal:  J Cell Mol Med       Date:  2017-12-14       Impact factor: 5.310

10.  SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway.

Authors:  Shan Tian; Pailan Peng; Jiao Li; Huan Deng; Na Zhan; Zhi Zeng; Weiguo Dong
Journal:  Aging (Albany NY)       Date:  2020-02-24       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.